Invites Biocore Co., Ltd. (XKON:A216400) agreed to acquire 85% stake in PROCAGEN from Byun Seok-soo for approximately KRW 12,748 million on July 14, 2022. PROCAGEN generated Total assets of KRW 1,101 million, Total equity of KRW 993 million and Net Income of KRW -528 million for the financial year 2021. Transaction is expected to close on July 15, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8,800 KRW | -3.30% | -2.87% | -5.38% |
1st Jan change | Capi. | |
---|---|---|
-5.38% | 49.03M | |
-19.78% | 10.91B | |
+44.90% | 3.3B | |
-33.46% | 2.19B | |
-14.31% | 2.16B | |
-28.86% | 1.5B | |
+25.34% | 1.09B | |
-3.28% | 737M | |
-35.33% | 404M | |
-46.53% | 386M |
- Stock Market
- Equities
- A216400 Stock
- News Invites Biocore Co., Ltd.
- Invites Biocore Co., Ltd. agreed to acquire 85% stake in PROCAGEN from Byun Seok-soo.